STUDIES ON THE PARGYLINE-BINDING SITE OF DIFFERENT TYPES OF MONOAMINE OXIDASEYU PH.1981; CAN. J. BIOCHEM.; ISSN 0008-4018; CAN; DA. 1981; VOL. 59; NO 1; PP. 30-37; ABS. FRE; BIBL. 30 REF.Article

DEVELOPMENT OF BENZYLAMINE OXIDASE AND MONOAMINE OXIDASE A AND B IN MANLEWINSOHN R; GLOVER V; SANDLER M et al.1980; BIOCHEM. PHARMACOL.; GBR; DA. 1980; VOL. 29; NO 9; PP. 1221-1230; BIBL. 49 REF.Article

TYPE B MONOAMINE OXIDASE ACTIVITIES TOWARD BETA -PHENYLETHYLAMINE IN DISCRETE HYPOTHALAMIC AND CIRCUMVENTRICULAR NUCLEI OF THE RATJANG SOO KIM; UCHIMURA H; HIRANO M et al.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 8; PP. 893-895; BIBL. 23 REF.Article

L-DEPRENYL, A SELECTIVE MONOAMINE OXIDASE TYPE-B INHIBITOR IN ENDOGENOUS DEPRESSIONMANN J; GERSHON S.1980; LIFE SCI.; GBR; DA. 1980; VOL. 26; NO 11; PP. 877-882; BIBL. 23 REF.Article

TWENTY-FOUR HOUR RHYTHM IN MONOAMINE OXIDASE ACTIVITY IN SPECIFIC AREAS OF THE RAT BRAIN STEMCHEVILLARD C; BARDEN N; SAAVEDRA JM et al.1981; BRAIN RES.; ISSN 0006-8993; NLD; DA. 1981; VOL. 223; NO 1; PP. 205-209; BIBL. 30 REF.Article

TYRAMINE ANTAGONISTIC PROPERTIES OF AGN 1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE OXIDASE TYPE BFINBERG JPM; TENNE M; YOUDIM MBH et al.1981; BR. J. PHARMACOL.; ISSN 0007-1188; GBR; DA. 1981; VOL. 73; NO 1; PP. 65-74; BIBL. 2 P.Article

THE EFFECT OF LIPID-DEPLETION ON THE KINETIC PROPERTIES OF RAT LIVER MONOAMINE OXIDASE-BFOWLER CJ; ORELAND L.1980; J. PHARM. PHARMACOL.; ISSN 0022-3573; GBR; DA. 1980; VOL. 32; NO 10; PP. 681-688; BIBL. 53 REF.Article

A BIOCHEMICAL MEASURE OF MONOAMINE OXIDASE TYPE A AND B INHIBITOR EFFECTS IN MANCAMPBELL IC; SHILLING DJ; LIPPER S et al.1979; J. PSYCHIATR. RES.; GBR; DA. 1979; VOL. 15; NO 2; PP. 77-84; BIBL. 16 REF.Article

PHENYLHYDRAZINE: SELECTIVE INHIBITION OF HUMAN BRAIN TYPE B MONOAMINE OXIDASEROTH JA; EDDY BJ; PEARCE LB et al.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 9; PP. 945-950; BIBL. 18 REF.Article

SUBSTRATE SELECTIVITY OF TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAINKINEMUCHI H; WAKUI Y; KAMIJO K et al.1980; J. NEUROCHEM.; GBR; DA. 1980; VOL. 35; NO 1; PP. 109-115; BIBL. 30 REF.Article

DISTRIBUTION OF TYPE A AND TYPE B MONOAMINE OXIDASE ACTIVITIES IN RAT AND CHICKEN SKELETAL MUSCLE AND NERVESMELTZER HY; ARORA RC.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 22; PP. 3261-3264; BIBL. 28 REF.Article

OXIDATION OF P-, M- AND O-TYRAMINE BY TYPE A AND TYPE B MONOAMINE OXIDASESUZUKI O; OYA M; KATSUMATA Y et al.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 17; PP. 2682-2684; BIBL. 24 REF.Article

EXPRESSION OF MONOAMINE OXIDASE A AND B ACTIVITIES IN MOUSE CYBRIDS AND HYBRIDSHAWKINS M JR; WALLACE DC; EISENSTADT JM et al.1981; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1981; VOL. 28; NO 4; PP. 425-432; BIBL. 38 REF.Article

SELECTIVE ACETYLENIC "SUICIDE" AND REVERSIBLE INHIBITORS OF MONOAMINE OXIDASE TYPES A AND BKALIR A; SABBAGH A; YOUDIM MBH et al.1981; BR. J. PHARMACOL.; ISSN 0007-1188; GBR; DA. 1981; VOL. 73; NO 1; PP. 55-64; BIBL. 2 P.Article

EVIDENCE FOR A SINGLE CATALYTIC BINDING SITE ON HUMAN BRAIN TYPE B MONOAMINE OXIDASE.ROTH JA.1976; J. NEUROCHEM.; G.B.; DA. 1976; VOL. 27; NO 5; PP. 1107-1112; BIBL. 24 REF.Article

THE DEAMINATION OF ISOAMYLAMINE BY MONOAMINE OXIDASE IN MITOCHONDRIAL PREPARATIONS FROM RAT LIVER AND HEART: A COMPARISON WITH PHENYLETHYLAMINEPEERS EM; LYLES GA; CALLINGHAM BA et al.1980; BIOCHEM. PHARMACOL.; GBR; DA. 1980; VOL. 29; NO 8; PP. 1097-1102; BIBL. 30 REF.Article

THE INTERACTION BETWEEN HUMAN PLATELET MONOAMINE OXIDASE, ITS MONOAMINE SUBSTRATES AND OXYGENFOWLER CJ; EKSTEDT B; EGASHIRA T et al.1979; BIOCHEM. PHARMACOL.; GBR; DA. 1979; VOL. 28; NO 20; PP. 3063-3068; BIBL. 35 REF.Article

THE EFFECT OF LIPOPHILIC COMPOUNDS UPON THE ACTIVITY OF RAT LIVER MITOCHONDRIAL MONOAMINE OXIDASE-A AND BFOWLER C; CALLINGHAM BA; MANTLE TJ et al.1980; BIOCHEM. PHARMACOL.; GBR; DA. 1980; VOL. 29; NO 8; PP. 1177-1183; BIBL. 48 REF.Article

Selegiline and Parkinson's disease protective and symptomatic condiserationsGOLBE, L. I; LANGSTON, J. W; SHOULSON, I et al.Drugs (Basel). 1990, Vol 39, Num 5, pp 646-651, issn 0012-6667Article

Effect of nonselective and selective inhibitors of monoamine oxidases A and B on pethidine toxicity in miceBODEN, R; BOTTING, R; COULSON, P et al.British journal of pharmacology. 1984, Vol 82, Num 1, pp 151-154, issn 0007-1188Article

Types A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of ratsWESTWOOD, N. N; BRYAN-LLUKA, L. J.The Journal of pharmacology and experimental therapeutics. 1993, Vol 267, Num 2, pp 815-821, issn 0022-3565Article

Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly formed dopamine in the rat kidneyFERANDES, M. H; SOARES-DA-SILVA, P.The Journal of pharmacology and experimental therapeutics. 1990, Vol 255, Num 3, pp 1309-1313, issn 0022-3565, 5 p.Article

Selective inhibition of MAO-A, not MAO-B, results in antidepressant-like effects on DRL 72-s behaviorMAREK, G. J; SEIDEN, L. S.Psychopharmacologia. 1988, Vol 96, Num 2, pp 153-160, issn 0033-3158Article

Tyramine kinetics and pressor sensitivity during monoamine oxiodase inhibition by selegilineSCHULZ, R; ANTONIN, K.-H; HOFFMANN, S et al.Clinical pharmacology and therapeutics. 1989, Vol 46, Num 5, pp 528-536, issn 0009-9236Article

Development of monoamine oxidase activity and monoamine effects on glutamate release in cerebellar neurons and astrocytesHERTZ, L; PENG, L; HERTZ, E et al.Neurochemical research. 1989, Vol 14, Num 10, pp 1039-1046, issn 0364-3190Article